Files
Download Full Text (819 KB)
Description
Introduction: There is little information on the basic epidemiologic and serologic profile(s) of the novel SARSCoV- 2 coronavirus especially in HCWs employed in rural settings. We embarked on a period seroprevalence study in the MaineHealth Cancer Network (MHCCN) to document Covid-19 exposure in our rural cancer care workforce. Our fundamental hypothesis is that despite implementing procedures to safeguard patients and the use of appropriate PPE in the care of known source patients/PUIs in both the inpatient and outpatient cancer care settings a small, but not insignificant number of cancer care providers (hereafter referred to as cancer HCWs) will have evidence of exposure by virtue of plasma antibody seroconversion.
Publication Date
2021
Publisher
MaineHealth
City
Portland, Maine
Keywords
COVID-19, antibody seroprevalence, Rural Settings, Pandemic, Cancer Healthcare Workers, Patient Care
Disciplines
Medical Education
Recommended Citation
Prescott, Jill; Knight, Caroline; Hobart, Erin; Saunders, Jamie; Caron, Kimberly; Neptune, Sandra; Brown, Patty; Lemire, Lisa; Breggia, Anne; Guierin-Staples, Susan L.; Lucas, Lee; Han, Paul; Kumar, Rachit; Carlson, Robert; and Remick, Scot, "A Period Seroprevalence (SARS-CoV-2) Survey in MHCCN Cancer Healthcare Workers (HCWs) Providing Patient Care during the Height of the Outbreak: A Registry Study (Initial Progress)" (2021). Costas T. Lambrew Research Retreat 2021. 6.
https://knowledgeconnection.mainehealth.org/lambrew-retreat-2021/6
